
Pharma Pulse 11/28/24: Solving Clinical Technology Challenges with Integration & more
The latest news for pharma industry insiders.
In this video interview, Jeff Sidell, PhD, chief technology officer, Advarra, highlights how integration can simplify processes.
These findings are significant in understanding interactions between glucagon-like peptide-1 medications and thyroid dysfunction because prior research has shown conflicting results.
Butterball started out with a boring, standard software implementation—and ended with the creation of a Thanksgiving turkey that you do not need to thaw.
The "Enterprise Tech Ecosystem Series: AbbVie Inc. - 2024" company profile has been added to ResearchAndMarkets.com's offering.
The report provides insights into AbbVie's tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.
Happy Thanksgiving to all of our readers, experts, and clients!
We're so thankful for all of the voices that help Pharmaceutical Commerce be an authority in the industry.
Looking forward to finishing out 2024 strong, and continued success and growth in 2025!
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

